Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,100
Total Claims
$1.2M
Drug Cost
1,459
Beneficiaries
$790
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+70%
Opioid rate vs peers
70.0% vs 41.3% avg
+98%
Cost per patient vs peers
$790 vs $399 avg
+160%
Brand preference vs peers
9.8% vs 3.8% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
70.0%
Opioid Rate
9,165
Opioid Claims
$554K
Opioid Cost
18.6%
Long-Acting Rate
This provider's opioid prescribing rate of 70.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,279 claims · $522K
Generic: 11,821 claims · $631K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 214 | $136K |
| Naproxen | 84 | $105K |
| Oxycodone Hcl | 2,723 | $71K |
| Oxycodone Hcl/Acetaminophen | 1,736 | $70K |
| Buprenorphine Hcl | 104 | $67K |
| Hydrocodone/Acetaminophen | 1,755 | $59K |
| Methylnaltrexone Bromide | 19 | $51K |
| Oxycodone Hcl | 77 | $48K |
| Naloxegol Oxalate | 56 | $33K |
| Sumatriptan | 47 | $29K |
| Ergotamine Tartrate/Caffeine | 18 | $27K |
| Morphine Sulfate | 966 | $26K |
| Diclofenac Sodium | 254 | $25K |
| Linaclotide | 28 | $20K |
| Buprenorphine | 43 | $19K |
Prescribing Profile
61
Unique Drugs
26.0
Anomaly Score
Patient Profile
64
Avg Age
61%
Female
2.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About